Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Regulus Therapeutics (RGLS)

0.9138 +0.0538 (+6.2558%)

8/23/2017  3:07pm

Open:

0.8800

Pre. Close:

0.8600

High:

0.9300

Low:

0.8714

Volume:

785,228

Market Cap:

94.84M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.9 - 0.91

0.91 - 0.94

Low:

0.77 - 0.78

0.78 - 0.8

Close:

0.83 - 0.86

0.86 - 0.9

Technical analysis  (as of: 2017-08-23 2:39:23 PM)

Overall:

      

Stoxline posted a STRONG BUY today, upgraded from lower rating. This stock seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 1.28     One year: 1.50

Support:

Support1: 0.79    Support2: 0.66

Resistance:

Resistance1: 1.09    Resistance2: 1.28

Pivot:

0.90

Moving Averages:

MA(5): 0.86     MA(20): 0.94

MA(100): 1.23     MA(250): 1.90

MACD:

MACD(12,26): -0.04     Signal(12,26,9): -0.04

%K %D:

%K(14,3): 29.90     %D(3): 18.21

RSI:

RSI(14): 47.28

52-Week:

High: 3.6500  Low: 0.7900  Change(%): -70.9

Average Vol(K):

3-Month: 73564  10-Days 9305

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
RGLS has closed below upper band by 40.9%. Bollinger Bands are 56.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to RGLS's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 23 Aug 2017 15:00:00 GMT
Putting Regulus Therapeutics Inc (RGLS) Under the Microscope: Technicals Watch

Tue, 22 Aug 2017 23:37:30 GMT
The One-Week Pre-earnings Momentum Trade With Options in Regulus Therapeutics Inc

Mon, 12 Jun 2017 10:52:30 GMT
Regulus Announces Pipeline Updates and Advancements

Tue, 25 Jul 2017 20:08:13 GMT
Regulus Announces Completion of Public Offering of Common Stock and Exercise ...

Wed, 19 Jul 2017 20:02:21 GMT
Regulus Announces Commencement of Public Offering of Common Stock

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

103.79

Shares Float (M)

58.80

% Held by Insiders

42.92

% Held by Institutions

65.50

Shares Short (K)

3630

Shares Short Prior Month (K)

2420

Stock Financials

EPS

-1.520

EPS Est. Current Year

-1.020

EPS Est. Next Year

-0.530

EPS Est. Next Quarter

-0.180

Forward EPS

-1.043

Book Value (p.s.)

0.730

PEG Ratio

-0.02

Profit Margin

Operating Margin

-29715.12

Return on Assets (ttm)

-50.0

Return on Equity (ttm)

-149.7

Qtrly Rev. Growth

-96.3

Gross Profit (p.s.)

0.011

Sales Per Share

EBITDA (p.s.)

-0.713

Qtrly Earnings Growth

Operating Cash Flow (M)

-66.61

Levered Free Cash Flow (M)

-36.41

FoxReading.com

Valuation

P/E

-0.60

P/E Growth Ratio

0.07

P/BV

1.26

P/S

P/CF

-1.43

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.